The stock price of Clorox Co. (NYSE: CLX) has dropped by -1.26 compared to previous close of 148.71. Despite this, the company has seen a fall of -2.07% in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-02 that Clorox (CLX) closed at $148.71 in the latest trading session, marking a -1.94% move from the prior day.
Is It Worth Investing in Clorox Co. (NYSE: CLX) Right Now?
The price-to-earnings ratio for Clorox Co. (NYSE: CLX) is above average at 230.76x, Company’s 36-month beta value is 0.42.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 13 as “hold,” and 1 as “sell.”
The public float for CLX is 123.84M, and currently, short sellers hold a 2.53% ratio of that floaft. The average trading volume of CLX on April 04, 2024 was 1.25M shares.
CLX’s Market Performance
CLX’s stock has seen a -2.07% decrease for the week, with a -2.72% drop in the past month and a 1.48% gain in the past quarter. The volatility ratio for the week is 1.39%, and the volatility levels for the past 30 days are at 1.81% for Clorox Co. The simple moving average for the last 20 days is -3.36% for CLX’s stock, with a simple moving average of 0.89% for the last 200 days.
Analysts’ Opinion of CLX
Many brokerage firms have already submitted their reports for CLX stocks, with Citigroup repeating the rating for CLX by listing it as a “Neutral.” The predicted price for CLX in the upcoming period, according to Citigroup is $165 based on the research report published on April 02, 2024 of the current year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see CLX reach a price target of $145. The rating they have provided for CLX stocks is “Hold” according to the report published on March 26th, 2024.
Goldman gave a rating of “Sell” to CLX, setting the target price at $140 in the report published on March 01st of the current year.
CLX Trading at -2.79% from the 50-Day Moving Average
After a stumble in the market that brought CLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.61% of loss for the given period.
Volatility was left at 1.81%, however, over the last 30 days, the volatility rate increased by 1.39%, as shares sank -2.05% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.87% upper at present.
During the last 5 trading sessions, CLX fell by -2.07%, which changed the moving average for the period of 200-days by -5.25% in comparison to the 20-day moving average, which settled at $151.79. In addition, Clorox Co. saw 2.97% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CLX starting from Jacobsen Kevin B, who sale 3,346 shares at the price of $160.82 back on Aug 14 ’23. After this action, Jacobsen Kevin B now owns 23,224 shares of Clorox Co., valued at $538,096 using the latest closing price.
Stock Fundamentals for CLX
Current profitability levels for the company are sitting at:
- 0.2 for the present operating margin
- 0.42 for the gross margin
The net margin for Clorox Co. stands at 0.01. The total capital return value is set at 0.38. Equity return is now at value 42.78, with 1.34 for asset returns.
Based on Clorox Co. (CLX), the company’s capital structure generated 0.98 points at debt to capital in total, while cash flow to debt ratio is standing at 0.3. The debt to equity ratio resting at 59.04. The interest coverage ratio of the stock is 16.24.
Currently, EBITDA for the company is 773.0 million with net debt to EBITDA at 2.82. When we switch over and look at the enterprise to sales, we see a ratio of 2.87. The receivables turnover for the company is 10.77for trailing twelve months and the total asset turnover is 1.24. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.89.
Conclusion
In a nutshell, Clorox Co. (CLX) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
